GeneCentric Therapeutics, a company making precision medicine more precise through gene expression.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 06/18/25 | $8,000,000 | Series C |
Alexandria Venture Investments Hatteras Venture Partners  IAG Capital Partners LabCorp | undisclosed |
